These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1637071)

  • 1. In vivo and in vitro pharmacologic profile of two new irreversible MAO-B inhibitors: MDL 72,974A and fluorodeprenyl.
    Terleckyj IA; Heikkila RE
    Ann N Y Acad Sci; 1992 May; 648():365-7. PubMed ID: 1637071
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxyl and peroxyl radical trapping by the monoamine oxidase-B inhibitors deprenyl and MDL 72,974A: implications for protection of biological substrates.
    Thomas CE; Huber EW; Ohlweiler DF
    Free Radic Biol Med; 1997; 22(4):733-7. PubMed ID: 9013137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and early clinical evaluation of selective inhibitors of monoamine oxidase.
    Palfreyman MG; McDonald IA; Bey P; Schechter PJ; Sjoerdsma A
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(6):967-87. PubMed ID: 3266532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled study of the tolerability and effects on platelet MAO-B activity of single oral doses of MDL 72.974A in normal volunteers.
    Hinze C; Harland D; Zreika M; Dulery B; Hardenberg J
    J Neural Transm Suppl; 1990; 32():203-9. PubMed ID: 2089092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDL 72,974A: a selective MAO-B inhibitor with potential for treatment of Parkinson's disease.
    Palfreyman MG; McDonald IA; Zreika M; Cremer G; Haegele KD; Bey P
    J Neural Transm Suppl; 1993; 40():101-11. PubMed ID: 8294896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo hydroxylation of the neurotoxin, 1-methyl-4-phenylpyridinium, and the effect of monoamine oxidase inhibitors: electrospray-MS analysis of intra-striatal microdialysates.
    Boismenu D; Mamer O; Ste-Marie L; Vachon L; Montgomery J
    J Mass Spectrom; 1996 Oct; 31(10):1101-8. PubMed ID: 8916419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDL 72,974: a potent and selective enzyme-activated irreversible inhibitor of monoamine oxidase type B with potential for use in Parkinson's disease.
    Zreika M; Fozard JR; Dudley MW; Bey P; McDonald IA; Palfreyman MG
    J Neural Transm Park Dis Dement Sect; 1989; 1(4):243-54. PubMed ID: 2597310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of pergolide and MDL 72974 on rat brain CuZn superoxide dismutase.
    Clow A; Freestone C; Lewis E; Dexter D; Sandler M; Glover V
    Neurosci Lett; 1993 Dec; 164(1-2):41-3. PubMed ID: 8152612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against DSP-4-induced neurotoxicity by deprenyl is not related to its inhibition of MAO B.
    Finnegan KT; Skratt JJ; Irwin I; DeLanney LE; Langston JW
    Eur J Pharmacol; 1990 Aug; 184(1):119-26. PubMed ID: 2120076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selectivity of MDL 72,974A for MAO-B inhibition based on substrate and metabolite concentrations in plasma.
    Huebert ND; Schwach V; Hinze C; Haegele KD
    Prog Brain Res; 1995; 106():135-42. PubMed ID: 8584649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific irreversible monoamine oxidase B inhibitors stimulate gene expression of aromatic L-amino acid decarboxylase in PC12 cells.
    Li XM; Juorio AV; Paterson IA; Zhu MY; Boulton AA
    J Neurochem; 1992 Dec; 59(6):2324-7. PubMed ID: 1431909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, 18F-Labeled Deuterated Fluorodeprenyl.
    Nag S; Fazio P; Lehmann L; Kettschau G; Heinrich T; Thiele A; Svedberg M; Amini N; Leesch S; Catafau AM; Hannestad J; Varrone A; Halldin C
    J Nucl Med; 2016 Feb; 57(2):315-20. PubMed ID: 26585057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different sensitivity of mitochondrial and cytosolic monoamine oxidases to in vivo but not in vitro inhibition by specific irreversible inhibitors.
    Moskvitina TA; Medvedev AE
    Med Sci Monit; 2001; 7(1):17-9. PubMed ID: 11208486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of a type B monoamine oxidase inhibitor, (E)-2-(4-fluorophenethyl)-3-fluoroallylamine (MDL-72974A), on semicarbazide-sensitive amine oxidases isolated from vascular tissues and sera of different species.
    Yu PH; Zuo DM
    Biochem Pharmacol; 1992 Jan; 43(2):307-12. PubMed ID: 1739419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B.
    Youdim MB; Gross A; Finberg JP
    Br J Pharmacol; 2001 Jan; 132(2):500-6. PubMed ID: 11159700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of long-term administration of isatin and himantan to mice on sensitivity of brain monoamine oxidase B to inhibition by deprenyl in vivo and in vitro].
    Val'dman EA; Kapitsa IG; Nerobkova LN; Aksenova LN; Buneeva OA; Medvedev AE
    Biomed Khim; 2004; 50(5):509-13. PubMed ID: 15628602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open multicenter study of the efficacy of MDL 72,974A, a monoamine oxidase type B (MAO-B) inhibitor, in Parkinson's disease.
    Myllylä VV; Sotaniemi KA; Aasly J; Sjaastad O; Rinne U; McIntyre T; Cremer G
    Adv Neurol; 1993; 60():676-80. PubMed ID: 8420209
    [No Abstract]   [Full Text] [Related]  

  • 18. Modulation of capsaicin induced airway reflexes in humans: effect of monoamine oxidase inhibition.
    Choudry NB; Studham J; Harland D; Fuller RW
    Br J Clin Pharmacol; 1993 Feb; 35(2):184-7. PubMed ID: 8443037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the B form selective monoamine oxidase inhibitor lose selectivity by long term treatment?
    Ekstedt B; Magyar K; Knoll J
    Biochem Pharmacol; 1979 Mar; 28(6):919-23. PubMed ID: 454488
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of chronic administration of inhibitors of flavin and quinone amine oxidases on imidazoline I(1) receptor density in rat whole brain.
    Holt A; Todd KG; Baker GB
    Ann N Y Acad Sci; 2003 Dec; 1009():309-22. PubMed ID: 15028605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.